Novelion Therapeutics Inc (NASDAQ:NVLN)

4.44
Delayed Data
As of Apr 20
 +0.04 / +0.91%
Today’s Change
3.08
Today|||52-Week Range
10.68
+42.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.0013.6M138.4M
 
 
 
Cost of Goods Sold0.000.003.6M50.1M
 
 
 
Depreciation And Amortization891.0K576.0K2.4M27.1M
 
 
 
 
 
 
Operating ExpensesGross Income-891.0K-576.0K7.6M61.2M
 
 
 
 
 
General Expenses20.4M16.0M44.3M145.5M
 
 
 
 
 
Research And Development13.8M9.8M14.8M49.0M
 
 
 
 
 
Total Operating Expenses21.3M16.6M50.3M222.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.3M-16.6M-36.7M-84.3M
 
 
 
 
 
Extraordinary Credit17.5M0.000.000.00
 
 
Extraordinary Charge-534.0K-6.7M-10.7M-2.5M
 
 
 
 
 
Interest Expense On Debt0.000.003.0M39.0M
 
 
 
Other Expenses53.0K81.0K-2.0M-292.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.2M-23.0M-52.4M-126.1M
 
 
 
 
 
Income Taxes-192.0K-22.0K-465.0K-583.0K
 
 
 
 
 
Discontinued Operations-66.0K0.000.000.00
 
 
Net Income-4.1M-23.0M-52.9M-126.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----11.3M18.6M
 
 
 
Shares To Calculate EPS Diluted----11.3M18.6M
 
 
 
 
Earnings Per ShareEPS-----$4.69-$6.81
 
 
 
EPS Diluted-----$4.69-$6.81